Concerns about potential adverse effects of testosterone on prostate have motivated the development of selective androgen receptor modulators that display tissue-selective activation of androgenic signaling. LGD-4033, a novel non steroidal, oral selective androgen receptor modulator, binds androgen receptor with high affinity and selectivity.
Potency :10mg/ ml
Appearance :Transparent oral solution.
Packing :30 ml / btl.
To evaluate the safety, tolerability, pharmacokinetics , and effects of ascending doses of LGD-4033, 76 healthy young men ( 21- 50 years old ) were randomized to receive a placebo or up to 1.0mg LGD-4043 daily for 21 days. It is all a favorable result , where there were no drug-related serious adverse events. Lean body mass increased dose dependently, but fat mass did not change significantly. LGD-4033 was safe, had favourable pharmacokinetic profile, and increased lean body mass even in short period without change in prostate-specific antigen. LIGANDROL is worth a consideration if you are opting to do a BRIDGE in between your cycle , for maintenance of your lean mass.
